SLAB51 to spare oxygen during infections from respiratory syncytial virus, COVID-19 and influenza By Professor Claudio De Simone From Medical Xpress Newspaper headlines from the U.S. to the U.K. and most places in between highlight the surge in sick patients suffering from respiratory viruses. The so-called "tripledemic" of lung [...]
Study confirms Probiotic SLAB51 benefits COVID-19 hypoxic patients Successful management of acute respiratory distress syndrome (ARDS) resulting from COVID-19 infection requires balancing adequate oxygenation and avoiding ventilator-induced lung injury (VILI). Recently reported data in Biomedicines (1) revealed that individuals with severe COVID-19 infections who required non-invasive oxygen therapy needed significantly less oxygen [...]
Researchers reveal that long term effects of post-COVID fatigue are currently under reported and poorly understood against the wider backdrop of the global pandemic. Fatigue can linger for several months after Covid-19, leaving people feeling dull and finding it difficult to concentrate and recall memories. The results of a clinical study [...]
Gut dysbiosis is an established key player in the pathogenesis and/or development of age-related neurodegeneration, such as Alzheimer’s disease (AD). By altering the intestinal permeability and the blood-brain barrier, gut dysbiosis can promote neuroinflammation, oxidation, amyloid-beta deposition, insulin resistance, and neuronal degeneration. Oral bacteriotherapy represents a promising approach to strategically modulate [...]
The probiotic Slab51 (Sivomixx®800, Ormendes, Switzerland) has been evaluated in sixty-nine adult COVID-19 patients with a confirmed diagnosis of SARS-CoV-2 related pneumonia a CT lung involvement greater than 50 percent and requiring non-invasive oxygen therapy. Patients supplemented with Slab51 in addition to standard therapy (n=40) showed significantly higher blood levels of partial [...]
Probiotics are considered the «snake oil» of the millennium, and doctors are reluctant to explore their full potential. However, preliminary data suggest that oral bacteriotherapy might be helpful in the management of COVID-19 infected patients. The danger would be to either downplay the results on the general conviction that probiotics are not [...]
The Sars-Cov-2 pandemic has shown that Covid-19 can move from the respiratory system, most vulnerable to the infection, and affect other organs and systems in the body. There is mounting evidence suggesting that the GI tract is involved in this disease. Hence the idea from the Chinese group coordinated by Dr. [...]
A new prospective in Covid-19 management comes from the journal Frontiers in Medicine. Understanding the invasive process of SARS-COV-2 has been essential to show that viral infection deeply destabilizes the gut-lung axis, causing alteration in the respiratory functions. The fact that pneumonia and gastrointestinal symptoms are predominant clinical manifestations of COVID-19 [...]
The Sars-Cov-2 coronavirus pandemic has spread widely around the world, causing often times serious clinical conditions such as severe pneumonia and cardiovascular syndrome, especially in patients with comorbidities, including diabetes and respiratory failure. Until a safe and effective vaccine is developed, the scientific community has highlighted some strategies to promptly intervene [...]